Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer.
Although great efforts have been made by clinicians and researchers, no significant …

The genotoxic methylating agents temozolomide (TMZ) and procarbazine and the
chloroethylating nitrosourea lomustine (CCNU) are part of the standard repertoire in the …

Glioblastomas (GBM) are considered one of the most aggressive tumors of the central
nervous system. The standard treatment for GBM-diagnosed patients implies surgery …

Temozolomide (TMZ) is the most preferred and approved chemotherapeutic drug for either
first-or second-line chemotherapy for glioma patients across the globe. In glioma patients …

Glioblastoma (GBM) is one of the most aggressive brain tumors and has a high recurrence
rate, and effective treatment is urgently needed. GBM stem cells (GSCs) contribute to GBM …

Gliomas are primary malignant brain tumors. These tumors seem to be more and more
frequent, not only because of a true increase in their incidence, but also due to the increase …

Simple Summary Glioblastoma is one of the most dangerous tumors of the central nervous
system, and still cannot be fully overcome. We still mainly rely on standard treatments …

Atmospheric pressure coaxial gaseous discharge tubes (DTs) with helium have
demonstrated potential for in vitro inactivation or sensitization of glioblastoma cancer cells …

Glioblastoma (GBM) represents a significant therapeutic challenge due to its aggressive
nature. Tumor Treating Fields (TTFields) present a promising approach to GBM therapy. The …

Background Glioblastoma multiforme (GBM) is an aggressive malignant tumor with a high
mortality rate and is the most prevalent primary intracranial tumor that remains incurable …